What is VIVS's relative strength rating?

VIVS ranks at the 5th percentile over 1 month, 2th percentile over 3 months, 2th percentile over 6 months, 5th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.

What sector is VIVS in?

VIVS is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.

Is VIVS in a leading sector?

Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). VIVS benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.

How volatile is VIVS?

VIVS currently shows a 20-day average daily range (ADR%) of 16.7%, a 90-day beta versus the S&P 500 of 3.40. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.

Does VIVS have a seasonal pattern?

TickerStance computes VIVS's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what VIVS has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

When did VIVS last report earnings?

VIVS most recently filed a 10-Q covering FY27 Q1 with the SEC on 2026-08-12. TickerStance sources earnings data from SEC EDGAR XBRL submissions and updates the fundamentals panel daily. The Pro dossier shows eight quarters of EPS and revenue trend, operating margin history, and a composite earnings-quality rank.

VivoSim Labs, Inc. Common Stock (VIVS) · RS 2

TODAY'S READ · AS OF 2026-08-24

As of 2026-08-24, VivoSim Labs, Inc. Common Stock (VIVS) has a 3-month relative strength percentile of 2 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 23. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 16.7%, relative volume 0.14×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.

RS methodology →

Market-wide RS; lit = leaderboard

Lenses lit

3 month2pctile

6 month2pctile

1 year5pctile

Classic2IBD pctile

LDR11leadership

0 of 5 lenses lit · avg RS pctile 5

✓ADR%16.7%✓A/DA!RVOL0.14×!$ Vol$4M

COMPUTED · AS OF 2026-08-24

Pattern read

VIVS is in a stage 4 downtrend, week 12. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -55.5% / -80.9%.

Pure factual computation. Not a recommendation. See stage analysis.

Market backdrop

47.8Neutral

Trend30% weight44.9 Breadth30% weight50.6 Leadership20% weight42.4 Macro20% weight59.0 Full stance breakdown →

Evidence · 1 of 3

Receipts behind the read

0 of 5 pass

Leadership

Is it leading?

Relative strength across horizons plus the leadership score.

1m

5

3m

2

6m

2

1y

5

LDR

—

StageWeinstein stage analysis

Stage 4 · Decline✓

Smart money

Who's accumulating?

Accumulation rating, relative volume, U/D ratio, breakout-day proof.

Fundamentals · VIVS

Does the business back the chart?

SEC EDGAR · last filing 10-Q · FY27 Q1 · period end 2026-06-30

94

Fundamentals Growth Rank

How does growth rank vs. the universe?

vs. 4,480 ranked stocks · Sector rank 94

View fundamental leadership map

Leader

Earnings

Is earnings accelerating?

Diluted EPS, last 8 quarters. Positive EPS uses YoY change.

Swung to loss

−$2.74—

24 Q2

−$1.68—

24 Q3

Evidence · 2 of 3

Sector context

Healthcare · 82th pctile in sector

Top peers · Healthcare

Who else is leading?

ELOX
99RS 3m
FBRX
99RS 3m
MRNA
99RS 3m
VIVS
2RS 3m · you

Sector vs market

Healthcare · 3 of 11

Energy100

Technology91

Healthcare82

Financials

PEERS · Pharmaceutical Products

Same industry, closest relative strength

4 peers · by RS6M

CMNDClearmind Medicine Inc. Common Shares2 IMMPImmutep Limited American Depositary Shares2 JUNSJupiter Neurosciences, Inc. Common Stock2 TENXTenax Therapeutics, Inc.3

§ Seasonality

10y · since 2025

Best monthJan on averageavg +61.33% · 100% win · n 1

Worst monthMar on averageavg -34.10% · 0% win · n 1

VIVS monthly seasonality strip
	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
1	VIVS Jan avg: 61.33% median: 61.33% win: 100% σ: 0.00% n: 1 2025-04-25 → 2026-07-31	VIVS Feb avg: -25.69% median: -25.69% win: 0% σ: 0.00% n: 1 2025-04-25 → 2026-07-31	VIVS Mar avg: -34.10% median: -34.10% win: 0% σ: 0.00% n: 1 2025-04-25 → 2026-07-31	VIVS Apr avg: 2.14% median: 2.14% win: 100% σ: 3.02% n: 2 2025-04-25 → 2026-07-31	VIVS May avg: -8.04% median: -8.04% win: 0% σ: 0.49% n: 2 2025-04-25 → 2026-07-31	VIVS Jun avg: -18.33% median: -18.33% win: 0% σ: 0.01% n: 2 2025-04-25 → 2026-07-31	VIVS Jul avg: -20.29% median: -20.29% win: 50% σ: 67.18% n: 2 2025-04-25 → 2026-07-31	VIVS Aug avg: 30.48% median: 30.48% win: 100% σ: 0.00% n: 1 2025-04-25 → 2026-07-31 (current)	VIVS Sep avg: 19.67% median: 19.67% win: 100% σ: 0.00% n: 1 2025-04-25 → 2026-07-31	VIVS Oct avg: -7.53% median: -7.53% win: 0% σ: 0.00% n: 1 2025-04-25 → 2026-07-31	VIVS Nov avg: -17.04% median: -17.04% win: 0% σ: 0.00% n: 1 2025-04-25 → 2026-07-31	VIVS Dec avg: -19.20% median: -19.20% win: 0% σ: 0.00% n: 1 2025-04-25 → 2026-07-31

ETF OWNERS

ETFs holding VIVS

VIVS appears in 1 ETF as of Mar 2026: VXF at 0.00% weight, $22K notional.

Held by 1 ETFs · $22K across latest filings · largest weight 0.00% (VXF).

ETFs holding: 1
Total value: $22K
Top 3 concentration: 100.0%
Max weight: VXF · 0.00%

Top 1 by value, from SEC N-PORT-P filings dated Mar 2026.

ETFs holding VIVS ranked by value
ETF	Weight	Value	Δ
VXFVanguard Extended Market ETF	0.00%	$22K	—

As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.

Public attention · VIVS

Is the crowd watching?

47/ 100 · vs its own 90-day norm▼ 5 vs 7dOverlooked

Weak relative strength and quiet attention. Little to read here either way.

Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.

News

Reference

Company snapshot

SectorHealthcare

IndustryPharmaceutical Products

SIC2836

Float11.9Mshares

Shares out13.4Mshares

Market cap$3.9MNano Cap

FAQ

Frequently asked questions

What is VIVS's relative strength rating?: VIVS ranks at the 5th percentile over 1 month, 2th percentile over 3 months, 2th percentile over 6 months, 5th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.
What sector is VIVS in?: VIVS is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.
Is VIVS in a leading sector?: Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). VIVS benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.
How volatile is VIVS?: VIVS currently shows a 20-day average daily range (ADR%) of 16.7%, a 90-day beta versus the S&P 500 of 3.40. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
Does VIVS have a seasonal pattern?: TickerStance computes VIVS's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what VIVS has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

VivoSim Labs, Inc. Common Stock (VIVS) — Stance & relative strength

Lenses lit

Pattern read

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Is earnings accelerating?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

§ Seasonality

ETFs holding VIVS

Is the crowd watching?

Company snapshot

Frequently asked questions

How much does it move?

Is revenue confirming?

Are margins expanding?

Share count: tailwind or headwind?

§ Seasonality

VivoSim Labs, Inc. Common Stock (VIVS) — Stance & relative strength

VIVS is not confirmed as a leader. 2 is not yet a leadership-grade RS read, Market Stance is 47.8

Lenses lit

Pattern read

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Is earnings accelerating?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

ETFs holding VIVS

Is the crowd watching?

Company snapshot

Frequently asked questions

How much does it move?

Is revenue confirming?

Are margins expanding?

Share count: tailwind or headwind?